Partial splenic embolization to permit continuation of systemic chemotherapy

Systemic chemotherapy treatments, commonly those that comprise oxaliplatin, have been linked to the appearance of distinctive liver lesions that evolves to portal hypertension, spleen enlargement, platelets sequestration, and thrombocytopenia. This outcome can interrupt treatment or force dosage red...

Descripción completa

Detalles Bibliográficos
Autores principales: Luz, Jose Hugo M., Luz, Paula M., Marchiori, Edson, Rodrigues, Leonardo A., Gouveia, Hugo R., Martin, Henrique S., Faria, Igor M., Souza, Roberto R., Gil, Roberto de Almeida, Palladino, Alexandre de M., Pimenta, Karina B., de Souza, Henrique S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083724/
https://www.ncbi.nlm.nih.gov/pubmed/27611010
http://dx.doi.org/10.1002/cam4.856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083724/
https://www.ncbi.nlm.nih.gov/pubmed/27611010
http://dx.doi.org/10.1002/cam4.856

Ejemplares similares